Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis

被引:253
|
作者
Lehrke, Michael [1 ]
Becker, Alexander [2 ]
Greif, Martin [2 ]
Stark, Renee [3 ]
Laubender, Ruediger P. [4 ]
von Ziegler, Franz [2 ]
Lebherz, Corinna [2 ]
Tittus, Janine [2 ]
Reiser, Maximilian [5 ]
Becker, Christoph [5 ]
Goeke, Burkhard [1 ]
Leber, Alexander W. [2 ]
Parhofer, Klaus G. [1 ]
Broedl, Uli C. [1 ]
机构
[1] Univ Munich, Dept Internal Med 2, D-81377 Munich, Germany
[2] Univ Munich, Dept Internal Med 1, D-81377 Munich, Germany
[3] Helmholtz Zentrum, Munich, Germany
[4] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany
[5] Univ Munich, Dept Radiol, Munich, Germany
关键词
ADIPOKINE; ADIPOCYTE;
D O I
10.1530/EJE-09-0380
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Chemerin is a recently discovered adipokine that regulates adipocyte differentiation and modulates chemotaxis and activation of dendritic cells and macrophages. Given the convergence of adipocyte and macrophage function, chemerin may provide an interesting link between obesity. inflammation and atherosclerosis in humans. We sought to examine the relationship of i) chemerin and markers of inflammation, ii) chemerin and components of the metabolic syndrome. and iii) chemerin and coronary atherosclerotic plaque burden and morphology. Design: Serum chemerin levels were determined in 303 patients with stable typical or atypical chest Pain Who Underwent dual-source multi-slice CT-angiography to exclude coronary artery stenosis. Atherosclerotic plaques were classified its calcified, mixed. or non-calcified. Results: Chemerin levels were highly correlated with high sensitivity C-reactive protein (r=0.44. P<0.0001). interleukin-6 (r=0.18, P=0.002), tumor necrosis factor-alpha. (r=0.24, P<0.0001). resistin (r=0.28. P<0.0001), and leptin r=0.36. P<0.0001) concentrations. Furthermore, chemerin was associated with components of the metabolic syndrome including body mass index (r=0.23, P=0.0002). triglycerides (r=0.29. P<0.0001), HDL-cholesterol (r=-0.18, P=0.003). and hypertension (P<0.0001). In bivariate analysis. chemerin levels were weakly correlated with coronary plaque burden (r=0.16. P=0.006) and the number of non-calcified plaques (r=0.14. P=0.02). These associations, however, were lost after adjusting for established cardiovascular risk factors (odds ratio. OR 1.17, 95%, confidence interval (Cl) 0.97-1.41. P=0.11 for coronary plaque burden: OR 1.06, 95% Cl 0.96-1.17. P=0.22 for non-calcified plaques). Conclusions: Chemerin is strongly associated with markers of inflammation and components of the metabolic syndrome. However, chemerin does not predict coronary, atherosclerosis.
引用
收藏
页码:339 / 344
页数:6
相关论文
共 50 条
  • [31] Hepatic insulin resistance in NAFLD: relationship with markers of atherosclerosis and metabolic syndrome components
    Privitera, Graziella
    Spadaro, Luisa
    Alagona, Corradina
    Calanna, Salvatore
    Piro, Salvatore
    Rabuazzo, Agata Maria
    Purrello, Francesco
    ACTA DIABETOLOGICA, 2016, 53 (03) : 449 - 459
  • [32] HEPATIC INSULIN RESISTANCE IN NAFLD: RELATIONSHIP WITH MARKERS OF ATHEROSCLEROSIS AND METABOLIC SYNDROME COMPONENTS
    Privitera, G.
    Spadaro, L.
    Alagona, C.
    Calanna, S.
    Rabuazzo, A. M.
    Purrello, F.
    DIGESTIVE AND LIVER DISEASE, 2015, 47 : E226 - E227
  • [33] Hepatic insulin resistance in NAFLD: relationship with markers of atherosclerosis and metabolic syndrome components
    Graziella Privitera
    Luisa Spadaro
    Corradina Alagona
    Salvatore Calanna
    Salvatore Piro
    Agata Maria Rabuazzo
    Francesco Purrello
    Acta Diabetologica, 2016, 53 : 449 - 459
  • [34] Metabolic syndrome versus infectious burden on the degree of inflammation and the severity of coronary atherosclerosis
    Dai, D.
    Kao, J. H.
    Hsu, C. N.
    Chiang, F. T.
    Huang, L. Y.
    Lin, J. L.
    Tseng, Y. Z.
    Hwang, J. J.
    EUROPEAN HEART JOURNAL, 2005, 26 : 357 - 357
  • [35] DOES ELEVATED ALANINE AMINOTRANSFERASE PREDICT COMPONENTS OF THE METABOLIC SYNDROME IN POLYCYSTIC OVARIAN SYNDROME?
    Aziz, N.
    Jones, H.
    Sprung, V. S.
    Irwin, A.
    Kemp, G. J.
    Cuthbertson, D.
    FERTILITY AND STERILITY, 2010, 94 (04) : S198 - S198
  • [36] Does metabolic syndrome predict significant angiographic coronary artery disease?
    Timoteo, Ana Teresa
    Carmo, Miguel Mota
    Ferreira, Rui Cruz
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2012, 31 (12) : 769 - 778
  • [37] Does metabolic syndrome predict silent carotid stenosis in coronary patients?
    Marco Ambrosetti
    Roberto F. E. Pedretti
    Internal and Emergency Medicine, 2008, 3 : 81 - 82
  • [38] Does metabolic syndrome predict silent carotid stenosis in coronary patients?
    Ambrosetti, Marco
    Pedretti, Roberto F. E.
    INTERNAL AND EMERGENCY MEDICINE, 2008, 3 (01) : 81 - 82
  • [39] Associations between metabolic syndrome components and markers of inflammation in Welsh school children
    Non Eleri Thomas
    David A. Rowe
    Elaine M. Murtagh
    Jeffrey W. Stephens
    Rhys Williams
    European Journal of Pediatrics, 2018, 177 : 409 - 417
  • [40] Associations between metabolic syndrome components and markers of inflammation in Welsh school children
    Thomas, Non Eleri
    Rowe, David A.
    Murtagh, Elaine M.
    Stephens, Jeffrey W.
    Williams, Rhys
    EUROPEAN JOURNAL OF PEDIATRICS, 2018, 177 (03) : 409 - 417